Updated on 18 July 2013
China’s State Food and Drug Administration has launched a six-month campaign that would target sales of illegal online drugs and fake traditional Chinese medicine
Singapore: China has announced a nationwide crackdown on the sale of illegal medicines, ahead of the GlaxoSmithKline bribery scandal that has questioned the regulations placed in the country.
The crackdown, said China's State Food and Drug Administration (SFDA) would last for six months and would aim at tightening industry regulation. The campaign will target illegal online drug sales and the sale of fake traditional Chinese medicine.
"We must resolutely punish illegal acts, expose illegal enterprises, recall problematic products," Mr Wu Zhen, the agency's deputy commissioner said in a statement.
The crackdown comes two days after Chinese police accused GlaxoSmithKline of bribing officials and doctors to boost sales and raise the price of its medicines in China.
The food and drug agency did not specifically mention GSK, but a spokesman for China's Commerce Ministry said authorities would not hold back punishing companies engaged in bribery.